Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

119.80
-1.7000-1.40%
Post-market: 119.800.00000.00%19:30 EDT
Volume:503.43K
Turnover:61.16M
Market Cap:9.96B
PE:-37.30
High:125.71
Open:122.87
Low:119.77
Close:121.50
52wk High:130.05
52wk Low:39.84
Shares:83.15M
Float Shares:70.11M
Volume Ratio:0.78
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2122
EPS(LYR):-3.6900
ROE:-24.15%
ROA:-15.59%
PB:6.60
PE(LYR):-32.47

Loading ...

Kymera Therapeutics to join Bank of America Healthcare Conference fireside chat

Reuters
·
May 06

Kymera says KT-579 Phase 1 healthy-volunteer trial data due in 2H 2026

Reuters
·
May 05

Jeito Capital appoints Elaine Caughey partner for business development, investor relations

Reuters
·
May 05

Barclays Sticks to Its Buy Rating for Kymera Therapeutics (KYMR)

TIPRANKS
·
May 01

Kymera Therapeutics price target lowered to $119 from $123 at Morgan Stanley

TIPRANKS
·
May 01

Earnings Flash (KYMR) Kymera Therapeutics Posts Q1 Net Loss $0.71 a Share, vs. FactSet Est of $0.88 Loss

MT Newswires Live
·
Apr 30

Kymera publishes corporate presentation on oral protein degraders for immunology medicines

Reuters
·
Apr 30

Kymera Therapeutics Q1 EPS $(0.71) Beats $(0.88) Estimate, Sales $34.365M Beat $8.614M Estimate

Benzinga Earnings
·
Apr 30

Kymera Q1 revenue jumps on Gilead milestone

Reuters
·
Apr 30

Kymera Q1 net loss widens to $69.2 million; collaboration revenues climb to $34.4 million

Reuters
·
Apr 30

BRIEF-Kymera Therapeutics Q1 EPS USD -0.71

Reuters
·
Apr 30

Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

GlobeNewswire
·
Apr 30

Kymera CEO Nello Mainolfi disposes of common shares worth $2,430,898.39

Reuters
·
Apr 30

Kymera director Bruce Booth disposes of common shares worth $538,687

Reuters
·
Apr 25

Kymera COO Jeremy Chadwick disposes 300 shares for $27,000

Reuters
·
Apr 25

Kymera Therapeutics to report first-quarter financial results, host webcast call

Reuters
·
Apr 23

Kymera COO Jeremy Chadwick disposes of USD 589,510 Kymera Therapeutics shares

Reuters
·
Apr 17

Kymera Therapeutics Chief Business Officer Noah Goodman sells 1,347 shares for $121,230

Reuters
·
Apr 17

Kymera director Bruce Booth disposes of common shares worth $836,290.08

Reuters
·
Apr 17

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Reuters
·
Apr 14